Primecap Management CO Astrazeneca PLC Transaction History

Primecap Management CO

$132 Billion
Q1 2024

A detailed history of Primecap Management CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Primecap Management CO holds 42,945,175 shares of AZN stock, worth $3.35 Billion. This represents 2.21% of its overall portfolio holdings.

Number of Shares

42,945,175

Previous 42,987,075 0.1%

Holding current value

$3.35 Billion

Previous $2.9 Billion 0.5%

% of portfolio

2.21%

Previous 2.32%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $2.56 Million - $2.91 Million	-41,900 Reduced 0.1%	42,945,175 $2.91 Billion
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $55.8 Million - $62.5 Million	-902,290 Reduced 2.06%	42,987,075 $2.9 Billion
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $12.2 Million - $13.5 Million	-187,935 Reduced 0.43%	43,889,365 $2.97 Billion
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $91.8 Million - $99.5 Million	-1,312,557 Reduced 2.89%	44,077,300 $3.15 Billion
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $25.5 Million - $28.9 Million	403,017 Added 0.9%	45,389,857 $3.15 Billion

Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $34 Million - $44.2 Million	-627,270 Reduced 1.38%	44,986,840 $3.05 Billion
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $10.6 Million - $27.1 Million	-199,710 Reduced 0.44%	45,614,110 $2.5 Billion
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $29.9 Million - $35.9 Million	-504,060 Reduced 1.09%	45,813,820 $3.03 Billion
Q1 2022 May 11, 2022	SELL	$55.72 - $67.12 $20.8 Million - $25 Million	-372,620 Reduced 0.8%	46,317,880 $3.07 Billion
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $85.1 Million - $101 Million	-1,575,750 Reduced 3.26%	46,690,500 $2.72 Billion
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $24.3 Million - $26.6 Million	-437,943 Reduced 0.9%	48,266,250 $2.9 Billion
Q2 2021 Aug 10, 2021	SELL	$48.42 - $60.18 $58.5 Million - $72.8 Million	-1,209,033 Reduced 2.42%	48,704,193 $2.92 Billion
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $9.23 Million - $10.7 Million	-195,720 Reduced 0.39%	49,913,226 $2.48 Billion
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $67.4 Million - $80.6 Million	-1,389,115 Reduced 2.7%	50,108,946 $2.5 Billion
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $115 Million - $132 Million	-2,163,676 Reduced 4.03%	51,498,061 $2.82 Billion
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $128 Million - $165 Million	-2,979,584 Reduced 5.26%	53,661,737 $2.84 Billion
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $80.9 Million - $110 Million	-2,141,045 Reduced 3.64%	56,641,321 $2.53 Billion
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $1.99 Million - $2.36 Million	-46,830 Reduced 0.08%	58,782,366 $2.93 Billion
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $31.5 Million - $35.7 Million	785,065 Added 1.35%	58,829,196 $2.62 Billion
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $63.4 Million - $70.9 Million	1,700,975 Added 3.02%	58,044,131 $2.4 Billion
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $6.93 Million - $8.4 Million	195,230 Added 0.35%	56,343,156 $2.28 Billion
Q4 2018 Feb 12, 2019	BUY	$36.86 - $41.49 $27.6 Million - $31.1 Million	748,640 Added 1.35%	56,147,926 $2.13 Billion
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $82.2 Million - $93.9 Million	2,364,013 Added 4.46%	55,399,286 $2.19 Billion
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $50.8 Million - $54.5 Million	1,469,835 Added 2.85%	53,035,273 $1.86 Billion
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $183 Million - $203 Million	5,552,804 Added 12.07%	51,565,438 $1.8 Billion
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $82.7 Million - $89.6 Million	2,577,104 Added 5.93%	46,012,634 $1.6 Billion
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $1.26 Billion - $1.48 Billion	43,435,530	43,435,530 $1.47 Billion

Others Institutions Holding AZN

# of Institutions

1,244

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Astrazeneca PLC Transaction History